CYP1B1-IN-6
CYP1B1-IN-6 (compound 19) is a fluorescence molecular probes which inhibits CYP1B1 activity. CYP1B1-IN-6 can identify tumor sites in fluorescence imaging and photoacoustic imaging modes.
For research use only. We do not sell to patients.
- CAS No.: 2952712-68-2
- Formula: C71H76FN3O22S4
- Molecular Weight:1470.63
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Chemical Information
-
CAS No. 2952712-68-2
-
Molecular Weight 1470.63
-
Formula C71H76FN3O22S4
-
SMILES
O=S(C1=C2C(C3=C([N+](CCCCCC(NCCOCCOCCOCCOC4=CC(C5=CC(C6=C(O5)C7=C(OC)C=CC(OC)=C7C(OC)=C6)=O)=CC(F)=C4)=O)=C(/C=C/C=C/C=C8N(CC)C9=C(C%10=CC(S(=O)(O)=O)=CC(S(=O)(O)=O)=C%10C=C9)C/8(C)C)C3(C)C)C=C2)=CC(S(=O)(O)=O)=C1)([O-])=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Bioluminescent/Fluorescent Imaging Xenograft
Bioluminescent and fluorescent imaging xenograft models use tumor cells engineered to express optical reporters so tumor engraftment, growth, dissemination, and treatment response can be monitored longitudinally in living animals and validated ex vivo. Bioluminescence imaging usually measures luciferase activity after substrate administration and is commonly used as a surrogate for viable reporter-expressing tumor burden, while fluorescence imaging measures reporter or probe emission and can support tumor localization, ex vivo confirmation, or complementary multimodal analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)